tradingkey.logo
tradingkey.logo
Search

National Research Corp

NRC
Add to Watchlist
19.510USD
+0.600+3.17%
Close 07-31 16:00ETQuotes delayed by 15 min
431.94MMarket Cap
48.73P/E TTM

More Details of National Research Corp Company

National Research Corporation, doing business as NRC Health, is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare organizations in the United States. Its digital solutions consist of four solution categories: Patient Experience, Consumer Experience, Employee Experience, and Market Experience, which can be implemented both collectively as an enterprise solution or individually to meet specific needs within the organization. Its Marketing solutions are subscription-based services that allow for improved tracking of awareness, perception, and consistency of healthcare brands; real-time assessment of competitive differentiators, and enhanced segmentation tools. Its Reputation solutions allow healthcare organizations to share a picture of their organization and ensure that timely and relevant content informs better consumer decision-making.

National Research Corp Info

Ticker SymbolNRC
Company nameNational Research Corp
IPO dateOct 01, 1997
CEOGreen (Trent S)
Number of employees368
Security typeOrdinary Share
Fiscal year-endOct 01
Address1245 Q Street
CityLINCOLN
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code68508
Phone14024752525
Websitehttps://nrchealth.com/
Ticker SymbolNRC
IPO dateOct 01, 1997
CEOGreen (Trent S)

Company Executives of National Research Corp

Name
Name/Position
Position
Shareholding
Change
Mr. Andrew (Andy) Monnich
Mr. Andrew (Andy) Monnich
Chief Corporate Development Officer
Chief Corporate Development Officer
100.00K
--
Mr. Michael D. Hays
Mr. Michael D. Hays
Chairman of the Board
Chairman of the Board
96.25K
--
Mr. John N. Nunnelly
Mr. John N. Nunnelly
Lead Independent Director
Lead Independent Director
40.36K
+19.07%
Dr. Stephen H. Lockhart, M.D., Ph.D.
Dr. Stephen H. Lockhart, M.D., Ph.D.
Independent Director
Independent Director
7.70K
--
Ms. Parul Bhandari
Ms. Parul Bhandari
Independent Director
Independent Director
7.70K
--
Dr. Donald M. Berwick
Dr. Donald M. Berwick
Independent Director
Independent Director
--
--
Dr. Penny A. Wheeler
Dr. Penny A. Wheeler
Independent Director
Independent Director
--
--
Ms. Helen L. Hrdy
Ms. Helen L. Hrdy
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Trent Green
Mr. Trent Green
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Shane Harrison
Mr. Shane Harrison
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Andrew (Andy) Monnich
Mr. Andrew (Andy) Monnich
Chief Corporate Development Officer
Chief Corporate Development Officer
100.00K
--
Mr. Michael D. Hays
Mr. Michael D. Hays
Chairman of the Board
Chairman of the Board
96.25K
--
Mr. John N. Nunnelly
Mr. John N. Nunnelly
Lead Independent Director
Lead Independent Director
40.36K
+19.07%
Dr. Stephen H. Lockhart, M.D., Ph.D.
Dr. Stephen H. Lockhart, M.D., Ph.D.
Independent Director
Independent Director
7.70K
--
Ms. Parul Bhandari
Ms. Parul Bhandari
Independent Director
Independent Director
7.70K
--
Dr. Donald M. Berwick
Dr. Donald M. Berwick
Independent Director
Independent Director
--
--

FAQs

Who are the top five shareholders of National Research Corp?

The top five shareholders of National Research Corp are: Mr. Andrew (Andy) Monnich

How many institutions hold shares of National Research Corp (NRC)?

As of 2026Q1, 322 institutions hold shares of National Research Corp, with a combined market value of approximately 12.06M, accounting for 53.51% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -824455.00.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.